Effect of Compound 21-A Selective Angiotensin II Type 2 Receptor Agonist in an Abdominal Adhesion Murine Model

被引：0
|
作者：
Boudreau, C. G. [1 ]
Levatte, T. [1 ]
Gareau, A. [2 ]
Legere, S. [1 ]
Bezuhly, M. [3 ]
机构：
[1] Dalhousie Univ, Med, Halifax, NS, Canada
[2] Calgary Lab Serv, Calgary, AB, Canada
[3] Dalhousie Univ, Dept Plast Surg, Halifax, NS, Canada
来源：
ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P317
引用
收藏
页码：S171 / S171
页数：1
相关论文
共 50 条
  • [31] Intranasal Trans-olfactory Delivery of the Angiotensin Type 2 Receptor Agonist Compound 21 is Neuroprotective in Ischemic Stroke
    Bennion, Douglas M.
    Isenberg, Jacob D.
    Dang, Alex N.
    Jones, Chad H.
    Graham, Justin T.
    Steckelings, Ulrike M.
    Sumners, Colin
    STROKE, 2017, 48
  • [32] Synergistic Inhibitory Effect of Rosuvastatin and Angiotensin II Type 2 Receptor Agonist on Vascular Remodeling
    Bai, Hui-Yu
    Mogi, Masaki
    Nakaoka, Hirotomo
    Kan-no, Harumi
    Tsukuda, Kana
    Wang, Xiao-Li
    Shan, Bao-Shuai
    Kukida, Masayoshi
    Yamauchi, Toshifumi
    Higaki, Akinori
    Min, Li-Juan
    Iwanami, Jun
    Horiuchi, Masatsugu
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 358 (02): : 352 - 358
  • [33] Anti-inflammatory action of angiotensin-(1-7) and the angiotensin type 2 receptor agonist Compound 21 in hypothalamic microglia
    Liu, Meng
    Shi, Peng
    Steckelings, Ulrike Muscha
    Sumners, Colin
    FASEB JOURNAL, 2013, 27
  • [34] ANGIOTENSIN AT2 RECEPTOR AGONIST, COMPOUND 21, PREVENTS ABDOMINAL AORTIC ANEURYSM PROGRESSION AND THE DECREASE OF AORTIC WALL DISTENSIBILITY IN THE RAT
    Lange, C.
    Sommerfeld, M.
    Namsolleck, P.
    Kintscher, U.
    Unger, T.
    KasChina, E.
    JOURNAL OF HYPERTENSION, 2017, 35 : E72 - E72
  • [35] A selective angiotensin-II type 2 receptor agonist reduced cancer cachexia-induced cardiomyopathy
    Konishi, M.
    Drescher, C.
    Tschirner, A.
    Coats, A. J.
    Anker, S. D.
    Springer, J.
    EUROPEAN HEART JOURNAL, 2015, 36 : 896 - 896
  • [36] Possible synergistic effect of direct angiotensin II type 2 receptor stimulation by compound 21 with memantine on prevention of cognitive decline in type 2 diabetic mice
    Iwanami, Jun
    Mogi, Masaki
    Tsukuda, Kana
    Jing, Fei
    Ohshima, Kousei
    Wang, Xiao-Li
    Nakaoka, Hirotomo
    Kan-no, Harumi
    Chisaka, Toshiyuki
    Bai, Hui-Yu
    Min, Li-Juan
    Horiuchi, Masatsugu
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 724 : 9 - 15
  • [37] Effects of compound 21, a non-peptide angiotensin II type 2 receptor agonist, on general anesthesia-induced cerebral injury in neonatal rats
    Yong, Jun
    Yan, Li
    Wang, Jing
    Xiao, Hongmei
    Zeng, Qingfan
    MOLECULAR MEDICINE REPORTS, 2018, 18 (06) : 5337 - 5344
  • [38] A Nonpeptide Angiotensin II Type 2 Receptor Agonist Prevents Pulmonary Fibrosis
    Horowitz, Alana
    Rathinasabapathy, Anandharajan
    Shenoy, Vinayak
    Horton, Kelsey
    Raizada, Mohan
    Steckelings, Ulrike
    Unger, Thomas
    Sumners, Colin
    Katovich, Michael
    FASEB JOURNAL, 2015, 29
  • [39] Facilitation of TRKB Activation by the Angiotensin II Receptor Type-2 (AT2R) Agonist C21
    Laukkanen, Liina
    Diniz, Cassiano R. A. F.
    Foulquier, Sebastien
    Prickaerts, Jos
    Castren, Eero
    Casarotto, Plinio C.
    PHARMACEUTICALS, 2021, 14 (08)
  • [40] Protective effects of the angiotensin II AT2 receptor agonist compound 21 in ischemic stroke: a nose-to-brain delivery approach
    Bennion, Douglas M.
    Jones, Chad H.
    Dang, Alex N.
    Isenberg, Jacob
    Graham, Justin T.
    Lindblad, Lena
    Domenig, Oliver
    Waters, Michael F.
    Poglitsch, Marko
    Sumners, Colin
    Steckelings, Ulrike Muscha
    CLINICAL SCIENCE, 2018, 132 (05) : 581 - 593
12345